瀛晟科學(00209.HK)年度虧損收窄少72.39%至4242.2萬港元
格隆匯3月18日丨瀛晟科學(00209.HK)公佈,截至2019年12月31日止年度,公司實現收入6.49億港元,同比增長1.98%,主要由於其玩具部門之表現所推動;由於產品價格提升,毛利7493.9萬港元,同比增長7.45%;公司擁有人應占期間虧損4242.2萬港元,同比減少72.39%;基本每股虧損1.16港仙;不派息。
由於玩具部門其中一名主要客户繼續開發及營銷熱門產品系列,玩具部門之收益增加2%至6.495億港元。由於致力提高產品售價及增加生產機器,毛利增加至7490萬港元。因此,玩具部門於2019財年錄得除税後分部溢利增加至1310萬港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.